Akanda Corp (AKAN)

[Scumbag Fraudsters]

AKAN~.9399 ~ALL BOTTOM, NO TOP.

[Scumbag Fraudsters]

AKAN down 75+ percent~~get in fast before it falls under 80¢ again.

[ALERTS100%to10000%GAIN]

AKAN~~.93,get in fast

[ALERTS100%to10000%GAIN]

lol from $1.00 to $10.00 dollars is 1000%%% bank,your math is bad

[ALERTS100%to10000%GAIN]

no worries I'll bank huge here,playing charts AKAN

[Scumbag Fraudsters]

That was for for spamming the board.

[Scumbag Fraudsters]

IT'S ON THE BOTTOM OF EVERY CHART FOR A F'N REASON!!!!!

You'll be lucky to ever get your $1.02 out of this money pit (if you really bought any).

NOTHING related to Halo is worth a F.

[ALERTS100%to10000%GAIN]

yes it is ,AKAN $1.00 and soon $10.00 pps,1000%% gain lol

[Scumbag Fraudsters]

YOUR ABACUS IS DEFECTIVE.

A 1000% increase is NOT $10!

I won't spoil your math lesson by telling you what it is.

[ALERTS100%to10000%GAIN]

AKAN~$1.02 ~ALL FREAKING BOTTOM BREAKING CHARTS to $10.00 dollars +++

DAILY and WEEKLY,,https://stockcharts.com/freecharts/gallery.html?akan

ADX (14)~ chart,,https://stockcharts.com/h-sc/ui?s=akan&p=D&yr=0&mn=6&dy=0&id=p46634481126

Stochastic ,FAST STO and FULL STO,,,https://stockcharts.com/h-sc/ui?s=akan&p=D&b=5&g=0&id=p21973678006

PSAR chart,,https://stockcharts.com/h-sc/ui?s=akan&p=D&yr=0&mn=6&dy=0&id=p91663972541

Daily chart,,https://stockcharts.com/h-sc/ui?s=akan&p=D&yr=0&mn=3&dy=0&id=p81682029007

MA(50),MA(200) and RSI(14),,https://stockcharts.com/h-sc/ui?s=akan&p=D&yr=0&mn=6&dy=0&id=p06455731712

Accum/Dist and MFI(14) chart,,,https://stockcharts.com/h-sc/ui?s=akan&p=D&yr=0&mn=6&dy=0&id=p31873288935

StockTA.com,,,http://www.stockta.com/cgi-bin/analysis.pl?symb=AKAN&cobrand=&mode=stock

[ALERTS100%to10000%GAIN]

AKAN~~$1.04,looks like breakout anytime,crazyy huge hammered oversold from $10.00pps to .80 cents http://charts.stockfetcher.com/sfchart/qGvP57Ijru.png

[ALERTS100%to10000%GAIN]

AKAN !! 1.03,,chart will go $10.00 pps to fill the GAP,better load fast,,http://charts.stockfetcher.com/sfchart/qGvP57Ijru.png

[ALERTS100%to10000%GAIN]

ACAN~~will move 1000%% to $10.00++ pps,watch this chart http://charts.stockfetcher.com/sfchart/87rJpzrBrX.png

[Scumbag Fraudsters]

You're calling for $10 here.

And $1000 here.

That's a ludicrous disparity.

[Scumbag Fraudsters]

That chart shows no such thing.

Are you on shrooms or something? Are you seeing things? Are you Okay?

This POS can't even get back to its $4 IPO price, and you're talkin' about $1000 per share.

[ALERTS100%to10000%GAIN]

AKAN~~look and learn, i'm a chart person ,is gonna blow 1000%% up from here,,http://charts.stockfetcher.com/sfchart/xFSy2krE9i.png

[ALERTS100%to10000%GAIN]

loaded at .$1.02 heavy,10 baggers here,heheheh lol

[Scumbag Fraudsters]

Desperate PUMPER on the board.

Their entire history is pumping and they probably don't own a share in anything.


There is no reason to believe this turd will go up this year.

[ALERTS100%to10000%GAIN]

AKAN will make a killing here,load big fellas,1000%%% easy bank

[ALERTS100%to10000%GAIN]

from $1.00 AKAN will run possible 1,000 %% up,$10.00 easy target

[ALERTS100%to10000%GAIN]

ACAN~~$1.06,load now and possible $5.00-$10.00 to fill the gap,News will come,load bigggg now

[ALERTS100%to10000%GAIN]

AKAN will run very hard, charts are ready,,http://charts.stockfetcher.com/sfchart/wy3Oz8ePAf.png

[Scumbag Fraudsters]

Well, you had a good (but brief) run there, Akanda.

Hope you enjoyed sticking your head into that clean air above a dollar.

Hold yer breath because you're going back under!

[TechnicalAnalyst1984]

When are they doing their "share consolidation" RS? An IPO and already doing an RS!

[Scumbag Fraudsters]

In what year will that happen?

Akanda's currently a barren wasteland with no marketable crops in the ground AFAIK.

It's so generous of Tetra Bio-Pharma to wait around for Akanda to build out its grow site, plant clones, harvest plants, dry and trim biomass, and finally ship weed from Africa to TBP in Canada in......2024?

Which begs the question: Why doesn't TBP just buy biomass NOW from Canopy Growth or from one of numerous other cannabis companies in North America?

Or even from the largest grower in Lesotho - MG Health, who also has GMP approval?

[Scumbag Fraudsters]

Up half a penny. Umm, yay?

And that minuscule bump was based on NOTHING.

Before you get too excited, the low was 83¢ - don't expect this to be the start of a rally.

Still goin' nowhere fast.

[Scumbag Fraudsters]

Who could get out?

Isn't everyone underwater by at least 75%?

[Scumbag Fraudsters]

Naw, look now.

Currently 89¢ - won't be long till it's 80¢ again.

[PennyPusher786]

Timbbbbbberrrr... hope all got out

[subslover]

Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug
Provides Tetra with stable supply of high-quality ingredients and regulatory-approved services to satisfy clinical trials and prescription products

Diversifies Akanda into cancer pain medical market as a specialized manufacturer of cannabis-based drugs for use in FDA clinical trials and pharmaceutical markets

LONDON and MONTREAL, July 12, 2022 /PRNewswire/ - Akanda Corp. ("Akanda") (NASDAQ: AKAN) and Tetra Bio-Pharma ("Tetra") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), today jointly announced that Akanda will supply Tetra with pharmaceutical grade cannabis flower in a microdose cap form, for use in a Storz & Bickel Mighty Medic Vaporizer for global commercialization of Tetra's QIXLEEFTM and related products. In addition, Akanda will act as a Contract Development and Manufacturing Organization (CDMO) for Tetra's clinical drug and commercial supply programs. With this project, Akanda becomes a CDMO in addition to being an EU GMP cannabis manufacturer, marking Akanda's first entry into cannabinoid drug development, which is a new and growing market opportunity for the company, while Tetra secures a stable supply of high-quality ingredients and regulatory-approved services to satisfy clinical trials and commercialization.

QIXLEEF™ is a proprietary botanical inhaled investigational new drug currently being studied in two U.S. Food and Drug Administration (FDA) authorized clinical trials: 1) REBORN©1, a Phase 2 study authorized by the FDA to evaluate inhaled cannabinoids against a class of immediate-release oral opioids for the management of breakthrough cancer pain, and 2) PLENITUDE©, a Phase 2 multicenter clinical trial authorized by the FDA to evaluate the safety and efficacy of inhaled cannabinoids to relieve uncontrolled pain in patients with advanced cancer. The companies estimate the total addressable market (TAM) for QIXLEEF™ to be nearly $1.7 billion by 20281.

Under the multi-year agreement, Akanda will supply Tetra with high-quality, premium THC and CBD flower, and will provide regulatory, quality and pharmaceutical manufacturing services for the QIXLEEFTM clinical drug development and marketing authorization from its Portugal operations. The supply of the active pharmaceutical ingredient starts in [the third quarter of] 2022 and is anticipated to increase incrementally over the succeeding years based on growing demand and commercializing of Tetra's cannabinoid-derived medicines.

1

Source: Derived from DelveInsight data encompassing the seven major markets, or 7MM, including the United States, Germany, France, Italy, Spain, United Kingdom and Japan.


Akanda will provide Tetra with a range of services, including regulatory affairs, quality control and stability testing through Akanda's internal lab, as well as manufacturing capabilities. Upon FDA approval, the anticipated supply commitments could reach [over 10 metric tonnes] per year.

Tetra, a leader in drug discovery and development for cannabinoid-based medicines, is focusing on therapeutic areas of inflammation, pain, ophthalmology and oncology through a robust pipeline using multiple delivery systems.

"This supply agreement with Tetra is a major milestone in Akanda's journey in becoming a cannabis platform company serving all regulated markets in the EMEA region," commented Tej Virk, CEO of Akanda. "In supporting a terrific partner with a mission to improve patient health and quality of life though cannabinoid-derived medicine, we are demonstrating that cannabis can fit into the traditional public sector model, with the expectation of reimbursement. Simultaneously, we are productively utilizing our diverse capabilities to support clinical trials for pharma grade cannabinoids. If approved, we expect to provide flower for the authorized compound, potentially creating a significant, incremental revenue stream for Akanda. This opportunity could only have been possible with our state-of-the-art facilities that we gained through the acquisition of Holigen in May."


"This collaboration transitions our Sintra facility into a global CDMO for cannabinoid-based pharmaceuticals as we build up our internal laboratory capacity and manufacturing under EU GMP," commented Dr. Akkar-Schenkl, President of Akanda. "Together with Tetra we are aiming to become the ambassadors for cancer pain treatment. The pharmaceutical grade flower and the level of pharmaceutical excellence in manufacturing, quality operations and regulatory affairs we will be providing into these projects is our fundamental commitment to worldwide palliative care in pain treatment in the field of oncology. The bioburden quality of the flower we will be providing for this delicate patient population can only be managed under stringent manufacturing conditions, special regulatory and pharmaceutical know-how."

"Tetra has been looking for quite a while to find a Global strategic CDMO partner, and we believe that Akanda is a perfect fit from a vision standpoint. This partnership will allow Tetra to secure a robust and trustable source for its clinical drug supply and for QIXLEEF™ commercialization plans. Aside from quality, Akanda will rapidly automate our process and increase our capacity, resulting in a 67% reduction of our cost of goods sold (COGS)," commented Guy Chamberland, M.Sc., Ph.D., Chief Executive Officer and Chief Regulatory Officer at Tetra. "Establishing a defined source of high-quality ingredients is important for Tetra, and we are excited to advance a productive collaboration with Akanda as we advance target drugs through the regulatory process."

About Akanda Corp.

Akanda (NASDAQ: AKAN) is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. Akanda's portfolio includes Bophelo Bioscience & Wellness, a GACP qualified cultivation campus in the Kingdom of Lesotho in Southern Africa; Holigen, a Portugal-based cultivator, manufacturer and distributor with a prized EU GMP certified indoor grow facility; and CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. The company's seed-to-patient supply chain also includes partnerships with Cellen Life Sciences' Leva Clinic, one of the first fully digital pain clinics in the UK, and Cantourage, which operates a platform for bringing medical cannabis to Europe.

Connect with Akanda: Email | Website | LinkedIn | Twitter | Instagram

About Tetra Bio-Pharma

Tetra Bio-Pharma (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Their evidence-based scientific approach has enabled them to develop a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. With patients at the core of what they do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing biopharma industry by regulators, physicians and insurance companies.

Connect with Tetra: Email | Website | LinkedIn | Twitter | Instagram

[PennyPusher786]

You spoke t9o soon

[Scumbag Fraudsters]

The market has spoken: Akanda's worth 80¢.

[Scumbag Fraudsters]

Tej must be so proud of his dying baby.

[Scumbag Fraudsters]

Maybe that was supposed to be big LUNCH?

DON'T LEAVE BEFORE THE BIG LAUNCH THIS WEEK!!

[Scumbag Fraudsters]

Nasdaq delisting warning soon, then comes the R/S.

[Scumbag Fraudsters]

D'oh! I forgot.

Really doesn't matter though - this trades like a stinky-pinky.

Akanda's been a snoozefest - no need to wake up. Down 72% from the offering price in its first 60 days, and currently down 77%.

They'll soon be ousted from the Nasdaq if they don't urgently rectify their paltry share price.

They've probably already planned and prepared for an R/S - the first of several to come.

Why else would they have joined Nasdaq with the minimum price needed to be there?

Halo is OTCQB, but it's run like a typical pinky scam.

[glens0]

I made $$$ here. By the way wake up AKAN is on the NASDAQ

[Scumbag Fraudsters]

Wise move.

Thought you were were making lots of $$$ here and preparing to buy more on a dip?

PRO TIP: Halo stocks don't have dips, they only have temporary pauses before sinking lower.

That always happens within minutes of my order filling.

Good luck finding an honest investment in OTC - I haven't.

[glens0]

Hey buddy you still hanging around. I moved on for now.

[Scumbag Fraudsters]

Keep your wallet handy, 'cause there's no doubt it'll keep dropping.

Averaging down on a Halo stock is a sure way to lose your entire investment.

[Scumbag Fraudsters]

DON'T LEAVE BEFORE THE BIG LAUNCH THIS WEEK!!

A little bird told me Akanda is a cash machine.

Hmmm, the birds name was Alfraud.

Once AKAN goes next week it's going to go big time imo. Anybody claiming different is shall we say, a fraud!

[TechnicalAnalyst1984]

It will probably keep dropping, I'm out. Consolidation. I think that's the new word for RS 1 for 20!

[Scumbag Fraudsters]

I can hardly wait for launch this week!

I guess today's 14.6% loss was from fueling the tanks?

Waiting bored...

[Scumbag Fraudsters]

Oh, NEXT week is the launch?

Why not THIS week?

Or LAST week?

Anybody claiming they can predict when Akanda will turnaround is, shall we say, a fraud.

Fraud tends to run in the Halo sphere, get used to it.

[Scumbag Fraudsters]

Obviously some don't comprehend the meaning of the words they use.

You said "initially."

Look it up.

[tmonkey]

took profit on my 1.20s all the way dn to .80--still have a handfull left to keep them on the radar---i think this co . will have a future but is really easy to manipulate with the sh structure---getting killed in that halo so needed the $ from this one bad----tmonkey

[glens0]

If AKAN keeps dropping I will have to buy back in

[TechnicalAnalyst1984]

Once AKAN goes next week it's going to go big time imo. Anybody claiming different is shall we say, a fraud!

[TechnicalAnalyst1984]

I ask for an example but instead you prove my point - IPO hits the market on the first day it's released by the underwriter and immediately has a drastic drop as they all do! And then they find their bottom and go up from there!

[Scumbag Fraudsters]

Here's one you may have heard of: AKAN

Shares of Akanda soared about 163% in its first day of trading.

You said "initially," and Akanda initially soared. There's your example. You're welcome.

TechnicalAnalyst1984

Friday, June 17, 2022 10:09:17 AM

Provide me an example of an IPO in the past year that does not initially drop drastically in price! Just 1 example please